Cite
APA Citation
Davis, E. J., Martin-Liberal, J., Kristeleit, R., Cho, D. C., Blagden, S. P., Berthold, D., Cardin, D. B., Vieito, M., Miller, R. E., Hari Dass, P., Orcurto, A., Spencer, K., Janik, J. E., Clark, J., Condamine, T., Pulini, J., Chen, X., & Mehnert, J. M. (2022). first-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors. Journal for immunotherapy of cancer, 10(10), . http://access.bl.uk/ark:/81055/vdc_100168596645.0x00000c